Polymorphic forms α, β, and γ of rifaximin | Patent Number 07612199

US 07612199 B2
Application Number12478638
Publication NumberUS 20090234114 A1
Pendency5 months, 2 days
Filled DateJun 4, 2009
Priority DateNov 4, 2004
Publication DateSep 17, 2009
Expiration DateNov 4, 2024
Inventor/ApplicantsManuela Campana
Guiseppe Glaudio Viscomi
Donatella Confortini
Vicenzo Cannata
Dario BRAGA
Goffredo ROSINI
Donatella CONFORTINI
Goffredo Rosini
Paolo RIGHI
Paolo Righi
Guiseppe Glaudio VISCOMI
Manuela CAMPANA
Vicenzo CANNATA
Dario Braga
ExaminesKIFLE, BRUCK
Art Unit1624
Technology Center1600
Assignments
Alfa Wassermann S.p.a.
Current
Alfa Wassermann S.p.a.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.